AC2592
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AC2592, covering 2015-01-19 to 2015-01-19. Get the full timeline:
Most recent: Clinical Trial Update: PROCLAIM: Effect of AC2592 Administered by Continuous Subcutaneous Infusion in Subjects With Advanced Chronic Congestive Heart Failure [Phase 2]